Form 8-K - Current report:
SEC Accession No. 0000950170-24-122826
Filing Date
2024-11-07
Accepted
2024-11-07 08:10:07
Documents
12
Period of Report
2024-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K thrd-20241107.htm   iXBRL 8-K 42047
2 EX-99.1 PRESS RELEASE ISSUED BY THIRD HARMONIC BIO, INC. thrd-ex99_1.htm EX-99.1 87061
  Complete submission text file 0000950170-24-122826.txt   254469

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT thrd-20241107.xsd EX-101.SCH 26014
14 EXTRACTED XBRL INSTANCE DOCUMENT thrd-20241107_htm.xml XML 4941
Mailing Address 1700 MONTGOMERY STREET SUITE 210 SAN FRANCISCO CA 94111
Business Address 1700 MONTGOMERY STREET SUITE 210 SAN FRANCISCO CA 94111 2097272457
Third Harmonic Bio, Inc. (Filer) CIK: 0001923840 (see all company filings)

EIN.: 834553503 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41498 | Film No.: 241433306
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)